EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:31282 - bevantolol hydrochloride
| Formula | C20H28NO4.Cl |
| Net Charge | 0 |
| Average Mass | 381.900 |
| Monoisotopic Mass | 381.17069 |
| SMILES | COc1ccc(CC[NH2+]CC(O)COc2cccc(C)c2)cc1OC.[Cl-] |
| InChI | InChI=1S/C20H27NO4.ClH/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3;/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3;1H |
| InChIKey | FJTKCFSPYUMXJB-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Roles: | calcium channel blocker One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| Applications: | anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| bevantolol hydrochloride (CHEBI:31282) has part bevantolol (CHEBI:238698) |
| bevantolol hydrochloride (CHEBI:31282) has role anti-arrhythmia drug (CHEBI:38070) |
| bevantolol hydrochloride (CHEBI:31282) has role antihypertensive agent (CHEBI:35674) |
| bevantolol hydrochloride (CHEBI:31282) has role calcium channel blocker (CHEBI:38215) |
| bevantolol hydrochloride (CHEBI:31282) has role β-adrenergic antagonist (CHEBI:35530) |
| bevantolol hydrochloride (CHEBI:31282) is a hydrochloride (CHEBI:36807) |
| Incoming Relation(s) |
| (R)-bevantolol hydrochloride (CHEBI:59186) is a bevantolol hydrochloride (CHEBI:31282) |
| (S)-bevantolol hydrochloride (CHEBI:59187) is a bevantolol hydrochloride (CHEBI:31282) |
| IUPAC Name |
|---|
| 1-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-3-(3-methylphenoxy)propan-2-ol hydrochloride |
| Synonyms | Source |
|---|---|
| (±)-1-((3,4-dimethoxyphenethyl)amino)-3-(m-tolyloxy)-2-propanol hydrochloride | ChemIDplus |
| 1-(3,4-dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol hydrochloride | ChEBI |
| bevantolol HCl | ChemIDplus |
| bevantolol hydrochloride | ChemIDplus |
| N-[2-(3,4-dimethoxyphenyl)ethyl]-2-hydroxy-3-(3-methylphenoxy)propan-1-aminium chloride | IUPAC |
| Manual Xrefs | Databases |
|---|---|
| D01369 | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| Beilstein:5195067 | Beilstein |
| CAS:42864-78-8 | KEGG DRUG |
| CAS:42864-78-8 | ChemIDplus |
| Citations |
|---|